John A. Lewicki Insider Trading
Get free email notifications about insider trading for John A. Lewicki.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A. Lewicki. John A. Lewicki is a EVP & Chief Scientific Officer in OncoMed Pharmaceuticals Inc ($OMED) and a EVP, Research & Development in OncoMed Pharmaceuticals Inc ($OMED) and a President in OncoMed Pharmaceuticals Inc ($OMED) and a President & CEO in OncoMed Pharmaceuticals Inc ($OMED) and a President and CEO in OncoMed Pharmaceuticals Inc ($OMED).
Address: C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY 94063 CA
Companies in which John A. Lewicki is an Insider
OncoMed Pharmaceuticals Inc
Trading Symbol: OMEDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John A. Lewicki: President and CEO, President & CEO, President, EVP, Research & Development, EVP & Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 23 2019
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John A. Lewicki
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2019 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President and CEO | Sell | U | 0.00 | 142,534 | 0 | 0 | 142.5 K to 0 (-100.00 %) |
Oct 11 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.01 | 1,156 | 2,324 | 55,966 | 57.1 K to 56 K (-2.02 %) |
Oct 10 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.13 | 2,296 | 4,888 | 57,122 | 59.4 K to 57.1 K (-3.86 %) |
Apr 26 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Sell | S | 2.68 | 4,557 | 12,202 | 55,418 | 60 K to 55.4 K (-7.60 %) |
Mar 19 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President & CEO | Option Exercise | A | 2.98 | 125,000 | 372,500 | 125,000 | |
Feb 23 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | President | Option Exercise | A | 2.23 | 125,000 | 278,750 | 125,000 | |
Jan 08 2018 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP, Research & Dev ... | Option Exercise | A | 3.98 | 100,000 | 398,000 | 100,000 |